When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Последний просмотренный: 15 Nov 2025
Last updated: 19 Nov 2024

Резюме

Определение

Анамнез и осмотр

Ключевые диагностические факторы

  • fatigue
  • weakness
  • lethargy
  • arthralgias
  • hepatomegaly
  • diabetes mellitus
  • impotence in males
  • amenorrhea
  • loss of libido
  • skin pigmentation
Полная информация

Другие диагностические факторы

  • congestive heart failure
  • arrhythmias
  • porphyria cutanea tarda
Полная информация

Факторы риска

  • middle age
  • male sex
  • white ancestry
  • family history
  • supplemental iron
Полная информация

Диагностические исследования

Исследования, которые показаны в первую очередь

  • serum transferrin saturation
  • serum ferritin
Полная информация

Исследования, проведение которых нужно рассмотреть

  • HFE mutation analysis
  • serum-based fibrosis tests/transient elastography
  • MRI liver
  • liver biopsy
  • LFTs
  • fasting blood sugar
  • echocardiogram
  • ECG
  • MRI heart and other organs
  • testosterone, FSH, and LH assays
  • bone densitometry
Полная информация

Алгоритм лечения

ПРОДОЛЖЕНИЕ

stage 0 disease (C282Y homozygous)

stage 1 disease (C282Y homozygous)

stage 2, 3, or 4 disease (C282Y homozygous)

not C282Y homozygous

Составители

Авторы

Kyle E. Brown, MD, Msc, FAASLD

Professor of Internal Medicine - Gastroenterology and Hepatology

Professor of Radiation Oncology

University of Iowa Carver College of Medicine

Iowa City

IA

Раскрытие информации

KEB declares that she has no competing interests.

Выражение благодарностей

Dr Kyle E. Brown would like to gratefully acknowledge Dr Rebecca Fischer Connor, the previous contributor to this topic. RFC declares that she has no competing interests.

Рецензенты

Pierre Brissot, MD

Professor of Medicine and Chief of Liver Disease Department

University Hospital Pontchaillou

Rennes

France

Раскрытие информации

PB declares that he has no competing interests.

William E. Cayley, MD MDiv

Associate Professor

Department of Family Medicine

University of Wisconsin

Madison

WI

Раскрытие информации

WEC declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Haute Autorité de Santé (France). Management of patients with HFE-related haemochromatosis (type 1 haemochromatosis). Jul 2005 [internet publication].Полный текст

Kowdley KV, Brown KE, Ahn J, et al. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019 Aug;114(8):1202-18.Полный текст  Аннотация

European Association for the Study of the Liver. EASL clinical practice guidelines on haemochromatosis. J Hepatol. 2022 Aug;77(2):479-502.Полный текст  Аннотация

Bacon BR, Adams PC, Kowdley KV, et al. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011 Jul;54(1):328-43.Полный текст  Аннотация

Fitzsimons EJ, Cullis JO, Thomas DW, et al. Diagnosis and therapy of genetic haemochromatosis (review and 2017 update). Br J Haematol. 2018 May;181(3):293-303.Полный текст  Аннотация

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности